Pharmaceutical Drug Risks Cases in California Court of Appeal

Browse 1 pharmaceutical drug risks cases decided by California Court of Appeal. AI-powered summaries, holdings, and legal analysis.

1
Cases
1
Defendant Win

Pharmaceutical Drug Risks Opinions from California Court of Appeal (1)

Mandell-Brown v. Novo Nordisk Inc.

Plaintiff's reliance claim fails in Victoza fraud case

California Court of Appeal · 2025-03-06 · Defendant Win · Impact: 20/100

Mandell-Brown v. Novo Nordisk Inc., decided by California Court of Appeal on March 6, 2025, resulted in a defendant win outcome. The plaintiff, Mandell-Brown, sued Novo Nordisk Inc. for alleged fraudu...

Frequently Asked Questions

Q: How many pharmaceutical drug risks cases has California Court of Appeal decided?

CaseLawBrief currently tracks 1 pharmaceutical drug risks cases from California Court of Appeal. This number is updated as new opinions are published.

Q: What types of outcomes occur in pharmaceutical drug risks cases at California Court of Appeal?

Outcome breakdown: Defendant Win: 1.

Q: Where can I find plain English summaries of pharmaceutical drug risks rulings from California Court of Appeal?

Each case page on CaseLawBrief includes an AI-generated plain English summary, key holdings, and legal analysis. Click any case above to read its full analysis.

Explore More

All California Court of Appeal Cases All Pharmaceutical Drug Risks Cases All Courts All Topics Search